Allergy Testing Access Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 24, 2021)
Allergy Testing Access Act of 2021
This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.
Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
What just happenedJun 25, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 24, 2021
- Jun 25, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 24, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 24, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jun 24, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 24, 2021IntroReferralIntro-H
Introduced in House
- Jun 24, 2021IntroReferral1000
Introduced in House